GRIFOLS | GRF - Equity Capital And Reserves


GRIFOLS reported EUR5.29B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Alcon AG USD 22.03B 52M Dec/2025
Almirall EUR 1.49B 24.03M Dec/2025
Amadeus IT EUR 4.85B 216.2M Dec/2025
Amarin USD 459.28M 387K Dec/2025
argenx SE USD 6.1B 597.47M Jun/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Cie Automotive EUR 1.45B 46.93M Dec/2025
Demant DKK 9.84B 446M Dec/2025
Ence Energia y Celulosa EUR 496.44M 106.36M Dec/2025
Essilor EUR 38.89B 1.07B Dec/2025
Ferrovial EUR 7.66B 11M Dec/2025
Fresenius EUR 18.62B 320M Sep/2025
Fresenius Medical Care EUR 249.82M 12.7B Dec/2025
Galapagos EUR 3.24B 788.91M Dec/2025
Genmab DKK 5.85B 96M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.29B 108.05M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Inditex 18.8B 1.84B Sep/2025
Merck EUR 28.59B 344M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Philips EUR 10.58B 204M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
Smith & Nephew USD 5.54B 331M Dec/2025
UCB EUR 10.87B 1.18B Dec/2025
Viscofan EUR 927.63M 23.29M Dec/2025